Search Results - "Dilmaghani‐Marand, Arezou"

Unveiling the lead exposure attributed burden in Iran from 1990 to 2019 through the lens of the Global Burden of Disease study 2019

Karimi, Hanie^{Aff1, Aff2}, Mahdavi, Sara^{Aff1, Aff3}, Moghaddam, Sahar Saeedi^{Aff1, Aff4}, Abbasi-Kangevari, Mohsen, Soleimani, Zahra, Esfahani, Zahra^{Aff1, Aff5}, Masinaei, Masoud^{Aff1, Aff6}, Fateh, Sahar Mohammadi, Golestani, Ali, Dilmaghani-Marand, Arezou, Kompani, Farzad, Rezaei, Negar, Ghasemi, Erfan, Larijani, Bagher, Farzadfar, Farshad^{Aff1, Aff9, IDs4159802458823z_cor15}

Plasma acylcarnitines and amino acids in dyslipidemia: An integrated metabolomics and machine learning approach

Etemadi, Ali^{Aff1, Aff2}, Hassanzadehkiabi, Farima, Mirabolghasemi, Maryam, Ahmadi, Mehdi, Dehghanbanadaki, Hojat, Hosseinkhani, Shaghayegh, Bandarian, Fatemeh, Najjar, Niloufar, Dilmaghani-Marand, Arezou, Panahi, Nekoo, Negahdari, Babak, Mazloomi, Mohammadali, Karimi-jafari, Mohammad Hossein, Razi, Farideh^{Aff1, IDs40200024013849_cor14}, Larijani, Bagher

Exploring metabolically healthy obesity: prevalence, characteristics, and cardiovascular risk in the Iranian population based on the STEPS 2021

Langroudi, Ashkan Pourabhari, Farzi, Yosef, Masinaei, Masoud^{Aff1, Aff2}, Varniab, Zahra Shokri, Shahin, Sarvenaz^{Aff1, Aff3}, Rashidi, Mohammad-Mahdi, Moghaddam, Sahar Saeedi^{Aff1, Aff4}, Rahimi, Shakiba, Khalili, Majid, Keykhaei, Mohammad^{Aff1, Aff5}, Ahmadi, Naser, Kazemi, Ameneh, Ghasemi, Erfan, Azadnajafabad, Sina, Yoosefi, Moein^{Aff1, Aff6}, Fattahi, Nima^{Aff1, Aff7}, Nasserinejad, Maryam^{Aff1, Aff8}, Rezaei, Nazila, Haghshenas, Rosa, Dilmaghani-Marand, Arezou, Abdolhamidi, Elham, Djalalinia, Shirin, Rezaei, Negar, Larijani, Bagher, Farzadfar, Farshad^{Aff1, Aff10, IDs40200023013645_cor25}

The diabetes cascade of care through the 14 years in Iran: findings of nationwide STEPS surveys 2007–2021

Ameli, Aslan, Sheikhy, Ali, Tabatabaei-Malazy, Ozra^{Aff1, Aff2}, Ahmadi, Naser, Ebrahimpur, Mahbube, Fallahzadeh, Aida, Rashidi, Mohammad-Mahdi, Golestani, Ali, Yoosefi, Moein^{Aff1, Aff4}, Farzi, Yosef, Dilmaghani-Marand, Arezou, Rezaei, Negar^{Aff1, Aff5}, Larijani, Bagher^{Aff2, IDs4020002301308z_cor13}, Farzadfar, Farshad^{Aff1, Aff2}

The national trend of the burden of Chronic Kidney Disease (CKD) in Iran from 1990 to 2019

Khashayar, Patricia^{Aff1, Aff2}, Sharifnejad Tehrani, Yeganeh, Tabatabaei-Malazy, Ozra^{Aff3, Aff4}, Khashayar, Pouria, Saeedi Moghaddam, Sahar^{Aff3, Aff6}, Shobeiri, Parnian, Golestani, Ali, Esfahani, Zahra^{Aff3, Aff7}, Shokri Varniab, Zahra, Nasserinejad, Maryam^{Aff3, Aff8}, Pourabhari Langroudi, Ashkan, Dilmaghani-Marand, Arezou, Kazemi, Ameneh, Rezaei, Negar^{Aff3, Aff4}, Larijani, Bagher^{Aff4, IDs4020002301298y_cor15}

‘Inequalities in prevalence of hypertension, prehypertension, anti-hypertensive coverage, awareness, and effective treatment in 429 districts of Iran; a population-based STEPS 2016 small area spatial estimation model’

Mohammadi, Esmaeil, Yoosefi, Moein, Shaker, Elaheh, Shahmohamadi, Elnaz, Ghasemi, Erfan, Ahmadi, Naser, Azadnajafabad, Sina, Rashidi, Mohammad-Mahdi, Rezaei, Nazila^{Aff1, Aff2}, Koolaji, Sogol, Dilmaghani-Marand, Arezou^{Aff1, Aff2}, Fateh, Sahar Mohammadi, Kazemi, Ameneh, Haghshenas, Rosa, Rezaei, Negar^{Aff1, IDs40200023011865_cor15}

Evaluation of the hypercholesterolemia care cascade and compliance with NCEP-ATP III guidelines in Iran based on the WHO STEPS survey

Djalalinia, Shirin^{Aff1, Aff2}, Khosravi, Sepehr^Aff1, Yoosefi, Moein^Aff3, Salahi, Sarvenaz, Varniab, Zahra Shokri, Golestani, Ali, Rezaei, Nazila, Kazemi, Ameneh, Dilmaghani-Marand, Arezou, Rezaei, Negar, Ghasemi, Erfan, Ahmadi, Naser, Rashidi, Mohammad-Mahdi, Farzi, Yosef, Rezaee, Kamyar, Nasserinejad, Maryam^{Aff1, Aff6}, Azadnajafabad, Sina, Abdolhamidi, Elham, Haghshenas, Rosa^{Aff1, Aff7}, Derouei, Arefeh Alipour, Rankohi, Azadeh Momen Nia, Farzadfar, Farshad^{Aff1, Aff5, IDs12944025025069_cor1}

Mechanistic Understanding of the Interactions between Nano-Objects with Different Surface Properties and α‑Synuclein

Mohammad-Beigi, Hossein^aff1, Hosseini, Atiyeh^{aff2, aff3}, Adeli, Mohsen^{aff4, aff5}, Ejtehadi, Mohammad Reza^{aff6, aff7}, Christiansen, Gunna^aff8, Sahin, Cagla^{aff1, aff9}, Tu, Zhaoxu^aff5, Tavakol, Mahdi^aff10, Dilmaghani-Marand, Arezou^aff11, Nabipour, Iraj^aff12, Farzadfar, Farshad^aff11, Otzen, Daniel Erik^{aff1, aff13}, Mahmoudi, Morteza^aff14, Hajipour, Mohammad Javad^{aff11, aff12}

The effect of Real-Time feedback and incentives on speeding behaviors using Telematics: A randomized controlled trial

Malekpour, Mohammad-Reza, Ghamari, Seyyed-Hadi, Ghasemi, Erfan, Hejaziyeganeh, Seyedamirhossein, Abbasi-Kangevari, Mohsen, Bhalla, Kavi, Rezaei, Nazila, Shahraz, Saeid, Dilmaghani-Marand, Arezou, Taghi Heydari, Seyed, Rezaei, Negar, Lankarani, Kamran B., Farzadfar, Farshad

Evaluation of the diabetes care cascade and compliance with WHO global coverage targets in Iran based on STEPS survey 2021

Azadnajafabad, Sina, Ahmadi, Naser, Rezaei, Negar, Rashidi, Mohammad-Mahdi, Saeedi Moghaddam, Sahar^{Aff1, Aff2}, Mohammadi, Esmaeil^{Aff1, Aff3}, Abbasi-Kangevari, Mohsen, Naderian, Mohammadreza^{Aff1, Aff4}, Ghasemi, Erfan, Farzi, Yosef, Kazemi, Ameneh, Dilmaghani-Marand, Arezou, Yoosefi, Moein^{Aff1, Aff5}, Rezaei, Shahabeddin^{Aff1, Aff6}, Nasserinejad, Maryam^{Aff1, Aff7}, Fattahi, Nima^{Aff1, Aff8}, Rezaei, Nazila, Haghshenas, Rosa, Foroutan Mehr, Elmira, Koolaji, Sogol, Razi, Farideh, Djalalinia, Shirin, Larijani, Bagher, Farzadfar, Farshad^{Aff1, Aff11, Aff12, IDs41598023394337_cor24}

Prevalence of plasma lipid abnormalities and associated risk factors among Iranian adults based on the findings from STEPs survey 2021

Khanali, Javad^{Aff1, Aff2}, Ghasemi, Erfan, Rashidi, Mohammad-Mahdi, Ahmadi, Naser, Ghamari, Seyyed-Hadi, Azangou-Khyavy, Mohammadreza^{Aff1, Aff2}, Malekpour, Mohammad-Reza, Abbasi-Kangevari, Mohsen, Hashemi, Seyedeh Melika, Naderian, Mohammadreza^{Aff1, Aff3}, Rezaei, Negar, Dilmaghani-Marand, Arezou, Farzi, Yosef, Kazemi, Ameneh, Yoosefi, Moein^{Aff1, Aff4}, Hajebi, Amirali, Rezaei, Shahabeddin^{Aff1, Aff5}, Azadnajafabad, Sina, Fattahi, Nima^{Aff1, Aff6}, Nasserinejad, Maryam^{Aff1, Aff7}, Abdolhamidi, Elham, Haghshenas, Rosa, Rezaei, Nazila, Djalalinia, Shirin, Larijani, Bagher, Farzadfar, Farshad^{Aff1, Aff9, IDs41598023423415_cor26}

Is elevated ALT associated with lifestyle risk factors? A population-based survey

Balali, Pargol^{Aff1, Aff2}, Nasserinejad, Maryam, Azadnajafabad, Sina, Ahmadi, Naser, Delavari, Farnaz, Rashidian, Laleh, Ghasemi, Erfan, Dilmaghani-Marand, Arezou, Fateh, Sahar Mohammadi^{Aff1, Aff3}, Ebrahimi, Narges, Kazemi, Ameneh, Derouei, Arefeh Alipour, Djalalinia, Shirin, Rezaei, Negar^{Aff1, Aff3, IDs40200022011376_cor14}, Delavari, Alireza^{Aff5, IDs40200022011376_cor15}

Targeted metabolomics analysis of amino acids and acylcarnitines as risk markers for diabetes by LC–MS/MS technique

Hosseinkhani, Shaghayegh^{Aff1, Aff2}, Arjmand, Babak, Dilmaghani-Marand, Arezou, Mohammadi Fateh, Sahar, Dehghanbanadaki, Hojat, Najjar, Niloufar, Alavi-Moghadam, Sepideh, Ghodssi-Ghassemabadi, Robabeh, Nasli-Esfahani, Ensieh, Farzadfar, Farshad^{Aff4, Aff8}, Larijani, Bagher, Razi, Farideh^{Aff1, Aff6, IDs41598022119707_cor12}

This result is not displayed to guests.
Login for full access.

Iranian population exposures to heavy metals, PAHs, and pesticides and their intake routes: a study protocol of a national population health survey

Soleimani, Zahra^{Aff1, Aff2}, Haghshenas, Rosa, Masinaei, Masoud, Naddafi, Kazem^{Aff1, Aff3}, Yunesian, Masud^{Aff1, Aff8}, Nabizadeh Nodehi, Ramin^{Aff1, Aff3}, Namazi, Nazli, Djazayeri, Abolghasem, Pouraram, Hamed, Hajipour, Mohammad Javad^{Aff2, Aff6}, Dilmaghani-Marand, Arezou^{Aff2, Aff7}, Mesdaghinia, Alireza^{Aff1, Aff9}, Farzadfar, Farshad^{Aff2, Aff7}

The prevalence, awareness, and treatment of lipid abnormalities in Iranian adults: Surveillance of risk factors of noncommunicable diseases in Iran 2016

Aryan, Zahra, Mahmoudi, Negar, Sheidaei, Ali, Rezaei, Shahabeddin, Mahmoudi, Zohreh, Gohari, Kimyia, Rezaei, Nazila, Hajipour, Mohammad Javad, Dilmaghani-Marand, Arezou, Razi, Farideh, Sabooni, Mahdi, Kompani, Farzad, Delavari, Alireza, Larijani, Bagher, Farzadfar, Farshad

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Detection and Discrimination of Bacterial Colonies with Mueller Matrix Imaging

Badieyan, Saeedesadat, Dilmaghani-Marand, Arezou, Hajipour, Mohammad Javad^{Aff2, Aff3}, Ameri, Ali, Razzaghi, Mohammad Reza, Rafii-Tabar, Hashem, Mahmoudi, Morteza^Aff5, Sasanpour, Pezhman^{Aff1, Aff6}

This result is not displayed to guests.
Login for full access.